ATOMICC/ GEICO 78-C

Trial Description: 
A randomize double-blinded, Placebo controlled, Phase II Trial of ANTI-PD1, TSR-042, as maintenance Therapy for patients with high-risk locallly advanced cervical cancer after chemo radiaton
Lead Cooperative Group: 
Disease Site: 
Cervical
Trial Status: 
Recruiting
Contact person: